Tezepelumab Phase 1 PK Study in Healthy Chinese Subjects

NCT04362410 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

BIOLOGICAL: Experimental: Tezepelumab
OTHER: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]